Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab.

Authors:
Vennapusa B; Baker B; Kowanetz M; Boone J; Menzl I and 15 more

Journal:
Appl Immunohistochem Mol Morphol

Publication Year: 2019

DOI:
10.1097/PAI.0000000000000594

PMCID:
PMC6369970

PMID:
29346180

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Appl Immunohistochem Mol Morphol

Abbreviation: Appl Immunohistochem Mol Morphol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Histocytochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Belgian Recommendations for Analytical Verification and Validation of Immunohistochemical Tests in …
Verbeke H; Van Hecke D; Bauraing C and 9 more (2023) - Transparency Score: 2/6
Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich…
Zhao Y; Huang T; Jin X and 2 more (2023) - Transparency Score: 3/6
Depigmentation of Melanin-containing Tissues Using Hypochlorous Acid to Enhance Hematoxylin-eosin a…
Wang L; Wang G. (2023) - Transparency Score: 2/6
Effect of Surface Decalcification With Hydrochloric Acid on the Determination of Estrogen Receptor,…
Ping W; Xin R; Li Z and 5 more (2023) - Transparency Score: 3/6
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer.
Weidemann S; Gorbokon N; Lennartz M and 20 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"B.V., B.B., M.K., J.B., I.M., J.-M.B., G.F., S. Mariathasan, S. Mocci, D.S., E.D., S.-Y.T., B.D., E.W., J.A.W., H.K., and Z.B. are employees of Roche-Genentech Ltd.; I.M., S.R., and P.S.H. are employees of Roche-Genentech Ltd and hold stock."

Evidence found in paper:

"Third-party medical writing assistance, under the direction of the authors, was provided by Louise Clarke, PhD, of Gardiner-Caldwell Communications, and was funded by Genentech Inc."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025